Internal Medicine, Rheumatology · New York, NY
NPI
1578740981
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1020 Park Ave
New York, NY, 10028
Phone (212) 870-8718
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
484 services
Medicare patients, 2024
165
Average age 71
Drug cost, 2024
$1.4M
861 prescriptions
Company payments, 2025
$3,660
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Weijia Yuan was code 99214 (office e&m - established), 420 times for 154 patients. In total Weijia Yuan billed 484 services in 7 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 420 | 154 | $111.12 | $47K |
| 99204 Office E&M - New | Office | 41 | 41 | $153.47 | $6,292 |
By year: 2022 $83K for 2,506 services; 2023 $55K for 1,345 services; 2024 $56K for 484 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 39 | 29 | $2.96 | $116 |
Medicare prescription drug claims, 2024
In 2024, the drug Weijia Yuan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 213 prescriptions and refills. In total Weijia Yuan wrote 861 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 213 | 499 | 66 | $6,664 |
| Otezla Apremilast | 62 | 62 | Under 11 | $306K |
| Methotrexate Methotrexate Sodium | 56 | 108 | 22 | $1,089 |
| Methylprednisolone Generic | 48 | 50 | 20 | $568 |
| Leflunomide Generic | 46 | 115 | 17 | $2,121 |
| Ibandronate Sodium Generic | 35 | 51 | Under 11 | $452 |
| Sulfasalazine Dr Sulfasalazine | 28 | 49 | Under 11 | $1,255 |
| Saphnelo Anifrolumab-Fnia | 27 | 27 | Under 11 | $135K |
| Enbrel Sureclick Etanercept | 26 | 26 | Under 11 | $189K |
| Pilocarpine Hcl Generic | 18 | 35 | Under 11 | $689 |
| Celecoxib Generic | 17 | 23 | Under 11 | $416 |
| Folic Acid Generic | 17 | 47 | Under 11 | $168 |
| Meloxicam Generic | 16 | 22 | Under 11 | $34.43 |
| Cyclobenzaprine Hcl Generic | 15 | 23 | Under 11 | $152 |
| Humira(Cf) Pen Adalimumab | 15 | 20 | Under 11 | $134K |
Brand drugs: 280 claims; generic drugs: 581 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Weijia Yuan $3,660 ($3,660 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $600.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $600 |
| Abbvie Inc. ABBV | 18 | $442 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $424 |
| UCB, Inc. UCB.BR | 11 | $344 |
| QOL Medical, LLC | 10 | $327 |
| Lilly USA, LLC LLY | 11 | $321 |
| Pfizer Inc. PFE | 15 | $275 |
| Janssen Biotech, Inc. JNJ | 8 | $222 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $216 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.